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Objective: The toxicity of ketamine to genitourinary system not only involved in lower urinary tract,
which include urinary frequency, urgency, suprapubic pain, dysuria and hematuria, but also upper uri-
nary tracts. However, the reports of ketmaine-induced upper urinary tract damage were rare.
Materials and methods: Herein, we reported nine ketamine abusers presented with moderate ﬂank pain
with hydronephrosis and lower urinary tract symptoms from three medical centers located around
Taiwan.
Results: All patients were diagnosed of hydronephrosis by sonography or abdominal computed to-
mography scans and 7 cases combined with acute kidney injury. They all receive ureteroscopy exam and
double-J stenting. All of their ﬂank pain and renal function impairment improved during follow up.
Conclusion: To the best of our knowledge, currently there is no standard therapy for ketamine-induced
nephropathy, we therefore supplied a therapeutic choice for those ketamine abuser combined with
hydronephrosis and/or acute kidney injury.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ketamine, an N-methyl-D-aspartate receptor antagonist, was
used to induce anesthesia due to its acute-onset and short-acting
characteristics. Ketamine is known to be a potent dissociative,
making the user feel that their mind has somehow become de-
tached from their body. In the meantime, ketamine is cheaper than
other drugs and easy to obtain1; therefore, ketamine has become a
popular recreational drug in nightclubs in recent years. However,
the impact of ketamine on the general system arouses society's
attention and imposes a great burden to health care resources.
Toxicity of ketamine in the genitourinary systemwas ﬁrst reported
in 2007 by Shahani et al.2 Since then, some researchers have sharedokang Hospital, Number 482,
2, Taiwan, ROC.
), meiyujang@yahoo.com.tw
ociation. Published by Elsevier Tatheir experiences of dealing with ketamine-induced uropathy pa-
tients in several reports. Around 20e30% of ketamine abusers
complain about lower urinary tract symptoms (LUTS), which
include urinary frequency, urgency, suprapubic pain, dysuria, and
hematuria.3 In addition to injury to the lower urinary tract, keta-
mine and its metabolites also devastate the upper urinary tract,
leading to varying degrees of hydronephrosis and renal function
impairment. Herein, we describe nine ketamine abusers with a
history of drug abuse for over 5 years, who suffered from bilateral
hydronephrosis; these nine patients came from three different
medical centers in Taiwan.
2. Case reports
A total of four male and ﬁve female ketamine abusers, aged
25e42 years (mean, 31 years), who underwent double-J stenting
due to hydronephrosis at three institutions (Kaohsiung Munic-
ipal Hsiao-Kang Hospital, Kaohsiung, Taiwan; Tungs' Taichungiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Table 1
Drug-using history and characteristics of patients.a
Patient no. Sex Age (y) Route of
administration
Duration of taking
ketamine (y)
Amount of
ketamine
taken (g/d)
Preoperative serum
creatinine (mg/dL)
Postoperative serum
creatinine (mg/dL)
Hydronephrosis
1 F 34 Snort 8 5e10 2.01 1.66 Bilateral/ Leftb
2 M 29 Snort 12 1e5 1.51 1.0 Bilateral
3 M 42 Snort 15 10 2.64 1.09 Bilateral
4 F 31 Snort 11 4 1.73 0.92 Bilateral
5 F 25 Snort 6 5 2.7 0.6 Bilateral
6 M 27 Snort þ smoking 5 5 1.5 1.04 Bilateral
7 F 30 Snort 5 2.5 0.75 0.45 Bilateral
8 F 28 Snort 4e5 1 2.15 1.08 Bilateral
9 M 31 Snort 2 5 0.7 0.58 Bilateral
Patient no. Severity of
hydronephrosisa
Level of
obstruction
Follow-up
period (mo)
Estimated GFR
(mL/min/1.73 m2)
Receive
URSdbiopsy
or not
Biopsy pathology result Persistent DJ stent
currently
DJ stent indwelling
duration (mo)
1 1 M/3 8 34.91 Y Cystitis cystica and
glandularis
Y (left)
2 2 L/3 12 54.17 N Y (bilateral)
3 2 L/3 48 71.96 Y Inﬂammation with
eosinophilic inﬁltration
Y (bilateral)
4 2 L/3 4 34 N Y (bilateral)
5 2 L/3 6 23.4 Y Fibroepithelial polyps Y (bilateral)
6 Left: 2
Right: 1
M/3 34 25 N N 18
7 3 L/3 27 42 N Y (bilateral)
8 3 L/3 49 43 N Y (bilateral)
9 Left: 4
Right: 3
L/3 18 >60 N N 12
F ¼ female; M ¼ male.
a Severity of hydronephrosis with renosonography: Grade 1 is anterioreposterior distance >5mm, Grade 2means calyx can be seen, Grade 3 is blunting calyces, and Grade 4
is cortical thinning.
b Bilateral hydronephrosis initially, then only the left side after months of follow-up.
Fig. 1. Ureterorenoscopic ﬁndings of Patient 1: anesthetized ureterorenoscope reveals
ureter polyps.
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Memorial Hospital, Taoyuan, Taiwan), were included in this
study. Characteristics of these patients are listed in Table 1. They
all came to hospitals with moderate ﬂank pain and severe LUTS,
including dysuria, frequency, urgency, and voiding pain. Three of
the patients also suffered from acute pyelonephritis with fever.
These three patients received antibiotic treatment initially. The
other patients had neither pyuria nor bacterial growth in urine
culture.
All patients had ultrasonographic evidence of hydronephrosis at
the time of diagnosis. Seven of these patients also had impaired
renal function (Table 1). The ﬁrst case revealed bilateral hydro-
nephrosis, with the creatinine level going up to 2.01 mg/dL at the
ﬁrst visit. During 1-month follow-up and cessation of ketamine
abuse, right hydronephrosis was subsided. As hydronephrosis with
persistent ﬂank pain continued, ureterorenoscopy was performed
to examine the cause of hydronephrosis. Inﬂammatory polyps over
the middle-third ureteral wall were noted during ureteroscopy
(Fig. 1) and were biopsied. A double-J stent was inserted at the end
of surgery. The pathology result of polyps was characterized by
cystical dilated luminal spaces and cuboidal to columnar appear-
ance of the umbrella cell layer representing a picture of chronic
inﬂammation. Scattered eosinophils were also seen focally (Fig. 2).
The other patients with bilateral hydronephrosis, acute kidney
injury, and ureter stenosis were examined by noncontrast
abdominal computed tomography (CT; Fig. 3). Ureteral polyps and
ulcerative ureteritis with mucosa erosion were discovered in all
nine patients while receiving bilateral ureterorenoscopy, and three
patients received polyp biopsy concurrently. These patients were
noted to have partial or complete recovery of renal function with
improvement in hydronephrosis after inserting a double-J stent.
Seven patients retained the indwelling double-J stent until now,
and in the other two patients the double-J stent was removed after18 months and 12 months, respectively, of follow-up. All these
patients were encouraged to discontinue ketamine abuse to pre-
vent further urinary function deterioration.
3. Discussion
Severe LUTS with chronic cystitis among ketamine abusers were
discussed in the literature; about 20e30% of patients may suffer
from LUTS.4 However, the adverse effect of ketamine on the upper
urinary tract is less investigated. In Chu et al's study,4 51% of
Fig. 2. (A) Cystitis cystica (arrow) and cystitis glandularis (arrowhead) (magniﬁcation
100). (B) Eosinophil inﬁltration (magniﬁcation 400).
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bilateral hydronephrosis found by sonography. Owing to its high
incidence and the fact that it may cause irreversible renal damage
with concomitant infection, determining the involvement of the
upper urinary tract is important. The actual mechanism of urinary
tract destruction is still not clear, but there are some hypotheses.Fig. 3. Noncontrast abdominal computed tomography of Patient 4 shows bilateral
hydronephrosis.Chu et al4 proposed that ketamine and its metabolites, such as
norketamine and dehydronorketamine, cause direct toxicity to
bladder epithelial cell, microvasculature toxicity, neural and
neurotransmitter toxic effects, or immunological reaction.5 We
supposed that the toxic effect of ketamine to ureteral urothelial cell
presents similar mechanism with lower urinary tract mucosa due
to the same structure. Although it is unclear whether the severity of
abuse is related to the severity of upper urinary tract damage, in
most of our patients, prolonged drug abuse and intake of a large
dosage of ketamine seem to have possibly caused ureteral inﬂam-
mation with hydronephrosis and renal function impairment.
Therefore, a close follow-up of renal function and imaging studies
are necessary for these high-risk patients.
The level of damage of the upper urinary tract in our patients is
concordantwith theﬁndings ofHuanget al,6whodiscoveredureteral
wall thickening with hydronephrosis, which is related to chronic
inﬂammation. In Huang et al's7 study, retrograde pyelography also
showed ureteral strictures with segmental beading, which were
characterized as “walking-stick ureters.” Abdominal CT is a useful
imaging tool to evaluate the cause of hydronephrosis and the extent
of obstruction. As we know, no previous studies have presented the
ureterorenoscopic picture of the ureteral wall. Among our patients,
ureteral wall thickening and inﬂammatory polyps occurred not just
at the vesicoureteric junction, these affected the entire ureter and/or
a part of the ureter away from the distal ureter, although most of the
literatures described that stenosis occurs at the vesicoureteric junc-
tion.1,4,8 This ﬁnding is also different from previous studies, which
suggested that most cases of hydronephrosis were the result of
impaired bladder compliance and vesicoureteral reﬂux.4,9 Ketamine
is metabolized by liver microsomal enzymes and excreted from the
kidney by conjugating to water-soluble glucuronide derivatives.10
From the pathological features of the ureteral wall, it presented
with inﬂammatory cell inﬁltration and ﬁbrosis, whichmay be caused
by the continuous contactwith a high concentration of ketamine and
itsmetabolites inurine. Fromour experience, LUTS aremore frequent
and appear earlier than upper urinary tract symptoms. We suppose
that the longer contact duration of toxic urine with the urothelium
might be a contributing factor.
There are several treatment choices for relief of hydronephrosis
with acute kidney injury, including percutaneous nephrostomy
insertion and double-J stenting for urinary diversion. Some physi-
cians may have a concern that the double-J stent will aggravate
LUTS due to contact with the bladder wall. However, in these pa-
tients, not only their ﬂank pain, impaired renal function, and
hydronephrosis were improved, but also LUTS did not get worse. In
fact, the crucial key to decrease the severity of LUTS is cessation of
ketamine use. Compared with percutaneous nephrostomy, the
double-J stent implantation is a less invasive procedure. In addition,
we can directly view the condition of the ureteral wall by ureter-
orenoscope and perform biopsy at the same time. It remained
unclear for how long the double-J stent should be indwelled or
when it should be removed. Some of these ketamine abusers even
tried to remove the double-J stent, but hydronephrosis and dete-
rioration of renal function were noted thereafter; therefore, a
double-J stent was inserted again.
It is still unknown when hydronephrosis and acute kidney
injury develop after ketamine abuse. Based on the experience of
our patients here, we can state that it may appear several years
later. Winstock et al11 emphasized that the harmful effects of ke-
tamine on the urinary tract are dose related, and it is compatible
with the ﬁndings in most of our patients who presented with
large-dosage dependency. Some of our cases achieved hydro-
nephrosis improvement after abstinence from ketamine abuse; by
contrast, when they continued to snort ketamine, the symptoms
progressed and the double-J stent had to be kept indwelled. In
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bladder wall. With respect to sequential LUTS and similar uro-
thelial structure, if a patient discontinued ketamine abuse when
LUTS occurred, it was postulated that the upper urinary tract
injury might decline.
In conclusion, LUTS are the principal presenting symptoms in
patients with ketamine abuse; however, ketamine-related upper
urinary tract injuries, including ureteral inﬂammation, ureteral
stricture, hydronephrosis, and impaired renal function, have drawn
physicians' attention in recent years. In our opinion, abdominal CT
andureterorenoscopyare important diagnostic tools forevaluationof
the extent of upper urinary tract damage. If ureteral stenosis with
inﬂammation, which leads to hydronephrosis and renal function
impairment, was found, preserving renal function and relieving
symptoms by urinary diversion are crucial. Nevertheless, the un-
derlyingmechanismandpathogenesis are not clear now. Longer time
is required to observe the disease progression, and also further ani-
mal or basic experimental research has to be conducted. We put
forward our experiences of treatment plan and propose our point of
view regarding treatment of patients with ketamine-induced
uropathy.
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